Vyndamax

Bayer pays $310M to buy into BridgeBio heart drug
BioPharma Dive
Mon, 03/4/24 - 11:52 am
BridgeBio
Bayer
acoramidis
Pfizer
Vyndamax
transthyretin amyloidosis cardiomyopathy
Pfizer Lawsuit Seeks to Block Generic Copy of Heart Disease Blockbuster
BioSpace
Mon, 08/14/23 - 06:47 pm
Pfizer
generics
legal
Vyndamax
heart disease
patents
tafamidis
Dexcel Pharma
Pfizer escapes proposed class action lawsuit over patient copay assistance
Fierce Pharma
Fri, 04/7/23 - 01:52 pm
Pfizer
legal
copay asssistance programs
Vyndaqel
Vyndamax
U.S. Supreme Court rebuffs Pfizer plan to help patients pay for heart medication
Reuters
Tue, 01/10/23 - 10:59 am
Pfizer
Supreme Court
Medicare
kickbacks
Vyndaqel
Vyndamax
Pfizer musters J&J, PhRMA's support in closely watched Vyndaqel copay assistance case at Supreme Court
Fierce Pharma
Tue, 11/15/22 - 10:32 am
Pfizer
JNJ
copay asssistance programs
kickbacks
Vyndaqel
Vyndamax
Supreme Court
Pfizer prohibited from subsidizing its heart drugs for Medicare patients
Beckers Hospital Review
Mon, 10/4/21 - 11:12 pm
Pfizer
Medicare
Vyndamax
Vyndaqel
Pfizer sues for U.S. permission to assist patients needing expensive heart drugs
Reuters
Fri, 06/26/20 - 07:45 pm
Pfizer
federal government
Medicare
Vyndaqel
Vyndamax
Can Pfizer Leap Over the Competition With This Potential Blockbuster?
Motley Fool
Wed, 05/8/19 - 10:03 am
Pfizer
Vyndamax
tafamidis
ATTR
Alnylam
Onpattro
Akcea Therapeutics
Tegsedi
Eidos Therapeutics
AG10
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
Xconomy
Mon, 05/6/19 - 10:54 am
FDA
Pfizer
tafamidis
Vyndaqel
Vyndamax
ATTR
Alnylam
Akcea